Piramal Pharma Ltd Quarterly Results
Q2 FY26-27 Results Summary
Revenue
The revenue stands at ₹2,617.06 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.29 per cent from ₹2,269.92 crore. This corresponds to a year-on-year *(YoY) growth of 28.05 per cent.
Operating Profit
Operating Profit stands at ₹348.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 78.66 per cent from ₹195.20 crore. This corresponds to a year-on-year *(YoY) growth of 119.76 per cent.
PBDT
PBDT stands at ₹314.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 45.67 per cent from ₹216.09 crore. This corresponds to a year-on-year *(YoY) growth of 100.93 per cent.
Profit Before Tax
Profit Before Tax stands at ₹81.63 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,194.24 per cent from ₹-7.46 crore. This corresponds to a year-on-year *(YoY) growth of 276.76 per cent.
Net Profit
Net Profit stands at ₹5.03 crore, reflecting a quarter-on-quarter *(QoQ) increase of 107.25 per cent from ₹-69.39 crore. This represents a 105.07 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Piramal Pharma Ltd News
Piramal Pharma Ltd Earnings
- YOY
- QOQ
Piramal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Piramal Pharma Ltd Research Reports
Piramal Pharma Ltd Financial Reports
Piramal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Piramal Pharma | 0.77% | 21.39% | 23.60% | 21.06% | 50.28% | 19.49% |
| Emcure Pharma | 0.50% | 0.12% | -3.16% | -4.53% | 5.16% | 41.64% |
| Sai Life | -0.04% | 5.05% | 3.14% | 17.10% | 44.01% | 69.06% |
| Acutaas Chemical | -0.16% | 5.31% | 28.13% | 28.09% | 49.38% | 120.56% |
| Wockhardt | 0.27% | 0.87% | -7.78% | -6.21% | 33.37% | 34.36% |
| Rubicon Research | 2.99% | 9.45% | 3.01% | 10.40% | 69.96% | 153.49% |
| Neuland Labs. | -1.88% | 0.20% | -11.56% | -1.43% | 19.80% | 12.71% |
Company Info
Company Information
Chairperson / Executive Director : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Independent Non Exe. Director : Nathalie Leitch
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Independent Non Exe. Director : Vibha Paul Rishi
Independent Non Exe. Director : AMIT SONI
Company Sec. & Compli. Officer : Maneesh Sharma